Innate Pharma SA（IPHA）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-19 | 6-K | — | SEC |
| 2026-08-14 | 6-K | — | SEC |
| 2026-08-10 | 6-K | — | SEC |
| 2026-07-23 | 6-K | — | SEC |
| 2026-07-21 | 6-K | — | SEC |
| 2026-05-22 | 6-K | — | SEC |
| 2026-05-19 | 6-K | — | SEC |
| 2026-05-13 | 6-K | — | SEC |
| 2026-05-12 | 6-K | — | SEC |
| 2026-05-06 | 6-K | — | SEC |
| 2026-04-23 | 6-K | — | SEC |
| 2026-04-17 | 6-K | — | SEC |
| 2026-04-13 | 6-K | — | SEC |
| 2026-04-13 | 6-K | — | SEC |
| 2026-04-08 | 6-K | — | SEC |
| 2026-04-03 | 6-K | — | SEC |
| 2026-04-02 | 6-K | — | SEC |
| 2026-03-26 | 6-K | — | SEC |
| 2026-03-19 | 6-K | — | SEC |
| 2026-02-18 | 6-K | — | SEC |
| 2026-01-07 | 6-K | — | SEC |
| 2025-12-22 | 6-K | — | SEC |
| 2025-12-11 | 6-K | — | SEC |
| 2025-11-28 | 6-K | — | SEC |
| 2025-11-17 | 6-K | — | SEC |
| 2025-11-13 | 6-K | — | SEC |
| 2025-11-10 | 6-K | — | SEC |
| 2025-11-05 | 6-K | — | SEC |
| 2025-10-15 | 6-K | — | SEC |
| 2025-09-17 | 6-K | — | SEC |
| 2025-09-17 | 6-K | — | SEC |
| 2025-09-15 | 6-K | — | SEC |
| 2025-09-10 | 6-K | — | SEC |
| 2025-09-02 | 6-K | — | SEC |
| 2025-08-04 | 6-K | — | SEC |
| 2025-07-29 | 6-K | — | SEC |
| 2025-07-07 | 6-K | — | SEC |
| 2025-06-17 | 6-K | — | SEC |
| 2025-06-13 | 6-K | — | SEC |
| 2025-05-27 | 6-K | — | SEC |
| 2025-05-23 | 6-K | — | SEC |
| 2025-05-23 | 6-K | — | SEC |
| 2025-05-19 | 6-K | — | SEC |
| 2025-05-15 | 6-K | — | SEC |
| 2025-05-13 | 6-K | — | SEC |
| 2025-05-12 | 6-K | — | SEC |
| 2025-05-06 | 6-K | — | SEC |
| 2025-04-30 | 6-K | — | SEC |
| 2025-04-29 | 6-K | — | SEC |
| 2025-04-28 | 6-K | — | SEC |
| 2025-04-24 | 6-K | — | SEC |
| 2025-04-23 | 6-K | — | SEC |
| 2025-04-16 | 6-K | — | SEC |
| 2025-04-16 | 6-K | — | SEC |
| 2025-04-03 | 6-K | — | SEC |
| 2025-03-27 | 6-K | — | SEC |
| 2025-03-26 | 6-K | — | SEC |
| 2025-03-25 | 6-K | — | SEC |
| 2025-03-20 | 6-K | — | SEC |
| 2025-02-27 | 6-K | — | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。